John D. Scandling

5.7k citations

102 papers · 4.0k indexed · h-index 34

Impact in

Transplantation top 0.05%
- Renal Transplantation Outcomes and Treatments
Nephrology top 0.5%

Papers in

Transplantation 54
- Renal Transplantation Outcomes and Treatments 54
Nephrology 20
- Dialysis and Renal Disease Management 9

Co-authors: Edward J. Alfrey Donald C. Dafoe Judith A. Shizuru Maria T. Millan Stéphan Busque Gabriel M. Danovitch Sussan Dejbakhsh‐Jones Robert Lowsky
Journals: Transplantation (26 papers)Clinical Transplantation (8 papers)American Journal of Transplantation (6 papers)The Journal of Urology (4 papers)American Journal of Physiology-Renal Physiology (4 papers)
Partner nations: United States Canada South Africa

In The Last Decade

John D. Scandling

101 papers receiving 3.9k citations

Peers

Countries citing papers authored by John D. Scandling

Since Specialization

Citations

This map shows the geographic impact of John D. Scandling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John D. Scandling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John D. Scandling more than expected).

Fields of papers citing papers by John D. Scandling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John D. Scandling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John D. Scandling. The network helps show where John D. Scandling may publish in the future.

Co-authors

The 25 scholars most cited alongside John D. Scandling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John D. Scandling Line = papers co-authored together John D. Scandling links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Pegloticase efficacy and safety in kidney transplant recipients; results of the phase IV, open‐label PROTECT clinical trial Clinical Transplantation ·Abdul Abdellatif, Lin Zhao, Jason Chamberlain, Katya Cherny, Yan Xin, Brad A. Marder, John D. Scandling, Kenneth G. Saag	2023	5
2	Successful Induction of Specific Immunological Tolerance by Combined Kidney and Hematopoietic Stem Cell Transplantation in HLA-Identical Siblings Frontiers in Immunology ·Thomas Fehr, Kerstin Hübel, Olivier de Rougemont, Irène A. Abela, Ariana Gaspert, Tayfun Güngör, Mathias Hauri, Birgit Helmchen, Claudia Linsenmeier, Thomas Müller, Jakob Nilsson, Oliver Riesterer, John D. Scandling, Urs Schanz, Pietro E. Cippà	2022	3
3	The organ procurement costs of expanding deceased donor organ acceptance criteria: Evidence from a cost function model American Journal of Transplantation ·Xingxing S. Cheng, Philip J. Held, Avi Dor, Jennifer L. Bragg‐Gresham, Jane C. Tan, John D. Scandling, Glenn M. Chertow, John P. Roberts	2021	8
4	Mixed chimerism and acceptance of kidney transplants after immunosuppressive drug withdrawal Science Translational Medicine ·Stéphan Busque, John D. Scandling, Robert Lowsky, Judith A. Shizuru, Kent P. Jensen, Jeffrey Waters, Hsin‐Hsu Wu, Kevin Sheehan, Asha Shori, Okmi Choi, Thomas Pham, Marcelo Fernández-Viña, Richard T. Hoppe, John Tamaresis, Philip W. Lavori, Edgar G. Engleman, Everett Meyer, Samuel Strober	2020	41
5	Macrochimerism and clinical transplant tolerance Human Immunology ·John D. Scandling, Stéphan Busque, Robert Lowsky, Judith A. Shizuru, Asha Shori, Edgar G. Engleman, Kent P. Jensen, Samuel Strober	2018	24
6	A Three-Gene Assay for Monitoring Immune Quiescence in Kidney Transplantation Journal of the American Society of Nephrology ·Silke Roedder, Li Li, Michael N. Alonso, Szu‐Chuan Hsieh, Minh Thien Vu, Hong Dai, Tara K. Sigdel, Ian C. Bostock, Camila Macedo, Diana Metes, A. Zeevi, Ron Shapiro, Oscar Salvatierra, John D. Scandling, Josefina Alberú, Edgar G. Engleman, Minnie Sarwal	2014	34
7	Outcomes After Kidney Transplantation of Patients Previously Diagnosed With Atrial Fibrillation American Journal of Transplantation ·Colin R. Lenihan, Maria E. Montez‐Rath, John D. Scandling, Mintu P. Turakhia, Wolfgang C. Winkelmayer	2013	38
8	The role of pre-emptive re-transplant in graft and recipient outcome Nephrology Dialysis Transplantation ·Alexander S. Goldfarb‐Rumyantzev, John F. Hurdle, Bradley C. Baird, Greg Stoddard, Zhi Wang, John D. Scandling, Lev L. Barenbaum, Alfred K. Cheung	2006	33
9	Validation of a screening protocol for identifying low‐risk candidates with type 1 diabetes mellitus for kidney with or without pancreas transplantation Clinical Transplantation ·Irene Ma, Hannah A. Valantine, Atsuko Shibata, Jane A. Waskerwitz, Donald C. Dafoe, Edward J. Alfrey, Jane C. Tan, Maria T. Millan, Stéphan Busque, John D. Scandling	2006	12
10	Kidney Transplant Candidate Evaluation Seminars in Dialysis ·John D. Scandling	2005	39
11	Increased expression of cytotoxic effector molecules: Different interpretations for steroid‐based and steroid‐free immunosuppression Pediatric Transplantation ·Thomas Satterwhite, Mei‐Sze Chua, Szu‐Chuan Hsieh, Stella Chang, John D. Scandling, Oscar Salvatierra, Minnie Sarwal	2003	33
12	A randomized, placebo-controlled trial of IGF-1 for delayed graft function: A human model to study postischemic ARF Kidney International ·Michelle Hladunewich, Geraldine Corrigan, Geraldine C. Derby, Deepa Ramaswamy, Neeraja Kambham, John D. Scandling, Bryan D. Myers	2003	52
13	Conversion of stable renal allograft recipients to a bioequivalent cyclosporine formulation Transplantation ·Allan M. Roza, Stephen J. Tomlanovich, Robert M. Merion, Raymond Pollak, Francis H. Wright, P. R. Rajagopalan, Timothy L. Pruett, John D. Scandling, Joan Ryan, Walid M. Awni, Sarah M. Schweitzer, Renee Greco, Wayne Lam, Azmi Nabulsi, Rebecca Hoffman	2002	31
14	RANDOMIZED TRIAL OF TACROLIMUS PLUS MYCOPHENOLATE MOFETIL OR AZATHIOPRINE VERSUS CYCLOSPORINE ORAL SOLUTION (MODIFIED) PLUS MYCOPHENOLATE MOFETIL AFTER CADAVERIC KIDNEY TRANSPLANTATION: RESULTS AT 2 YEARS1 Transplantation ·Nasimul Ahsan, Christopher P. Johnson, Thomas A. Gonwa, Philip F. Halloran, Mark D. Stegall, Mark A. Hardy, Robert A. Metzger, Charles F. Shield, Leslie Rocher, John D. Scandling, John B. Sorensen, Laura Mulloy, Jimmy A. Light, Claudia Corwin, Gabriel M. Danovitch, Michael Wachs, Paul VanVeldhuisen, K. Salm, D. Tolzman, William E. Fitzsimmons	2001	116
15	RANDOMIZED TRIAL OF TACROLIMUS (PROGRAF) IN COMBINATION WITH AZATHIOPRINE OR MYCHOPHENOLATE MOFETIL VERSUS CYCLOSPORINE (NEORAL) WITH MYCOPHENOLATE MOFETIL AFTER CADAVERIC KIDNEY TRANSPLANTATION1, 2 Transplantation ·Christopher P. Johnson, Nasimul Ahsan, Thomas A. Gonwa, Philip F. Halloran, Mark D. Stegall, Mark A. Hardy, Robert A. Metzger, Charles F. Shield, Leslie Rocher, John D. Scandling, John B. Sorensen, Laura Mulloy, Jimmy A. Light, Claudia Corwin, Gabriel M. Danovitch, Michael Wachs, Paul VanVeldhuisen, K. Salm, D. Tolzman, William E. Fitzsimmons	2000	229
16	Use of an augmented urinary bladder can be catastrophic in renal transplantation Transplantation Proceedings ·Edward J. Alfrey, Susan B. Conley, Diana C. Tanney, Robert H. Mak, John D. Scandling, Donald C. Dafoe, Gregory B. Hammer, Pamela Orlandi, Oscar Salvatierra, Leigh Page	1997	29
17	OUTCOMES IN DIABETIC PATIENTS AFTER SIMULTANEOUS PANCREAS-KIDNEY VERSUS KIDNEY ALONE TRANSPLANTATION1 Transplantation ·Crystine M. Lee, John D. Scandling, Nancy Krieger, Donald C. Dafoe, Edward J. Alfrey	1997	14
18	Postischemic injury, delayed function and Na+/K+-ATPase distribution in the transplanted kidney Kidney International ·Veludina S.J. Alejandro, W. James Nelson, Phil Huie, Richard K. Sibley, Donald C. Dafoe, Paul C. Kuo, John D. Scandling, Bryan D. Myers	1995	69
19	POSTTRANSPLANT LYMPHOPROLIFERATTVE DISORDERS AND EPSTEIN-BARR VIRUS PROPHYLAXIS Transplantation ·Paul C. Kuo, Donald C. Dafoe, Edward J. Alfrey, Richard K. Sibley, John D. Scandling	1995	30
20	Mechanisms of filtration failure during postischemic injury of the human kidney. A study of the reperfused renal allograft. Journal of Clinical Investigation ·Vazquez Sanchez Alejandro, John D. Scandling, R K Sibley, Donald C. Dafoe, Edward J. Alfrey, WM Deen, B. D. Myers	1995	99

About John D. Scandling

John D. Scandling is a scholar working on Transplantation, Nephrology, Surgery, Public Health, Environmental and Occupational Health and Hematology, having authored 102 papers that have together received 4.0k indexed citations. Recurring topics across this work include Renal Transplantation Outcomes and Treatments (54 papers), Organ Transplantation Techniques and Outcomes (37 papers), Organ Donation and Transplantation (26 papers), Renal and Vascular Pathologies (13 papers), Transplantation: Methods and Outcomes (10 papers), Dialysis and Renal Disease Management (9 papers), Hematopoietic Stem Cell Transplantation (8 papers) and Urinary Bladder and Prostate Research (5 papers). The work is most often cited by research in Transplantation (2.3k citations), Nephrology (748 citations), Hematology (461 citations), Surgery (1.5k citations) and Public Health, Environmental and Occupational Health (1.0k citations). John D. Scandling has collaborated with scholars based in United States, Canada and South Africa. Frequent co-authors include Edward J. Alfrey, Donald C. Dafoe, Judith A. Shizuru, Maria T. Millan, Stéphan Busque, Gabriel M. Danovitch, Sussan Dejbakhsh‐Jones, Robert Lowsky, Samuel Strober and Edgar G. Engleman. Their work appears in journals such as Transplantation, Clinical Transplantation, American Journal of Transplantation, The Journal of Urology and American Journal of Physiology-Renal Physiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact